Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy
Titel:
Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy
Auteur:
Schwartzberg, L. Roeland, E. Andric, Z. Kowalski, D. Radic, J. Voisin, D. Rizzi, G. Navari, R. Gralla, R.J. Karthaus, M.